Skip to main content
Top
Published in: International Ophthalmology 1/2017

01-02-2017 | Original Paper

N-acetylcysteine supplementation reduces oxidative stress for cytosine arabinoside in rat model

Authors: Yasemin Isik Balci, Semra Acer, Ramazan Yagci, Vural Kucukatay, Hakan Sarbay, Kerem Bozkurt, Aziz Polat

Published in: International Ophthalmology | Issue 1/2017

Login to get access

Abstract

Cytosine arabinoside (ARA-C) is a pyrimidine analog that may cause keratoconjunctivitis when used in high doses. The underlying mechanism may be the increased amounts of reactive oxygen radicals that may damage the DNA synthesis of corneal and conjunctival epithelial cells. Topical corticosteroids are one of the prophylactic treatments for keratoconjunctivitis induced by ARA-C. Forty Wistar-type albino rats were included in this study the rats were divided into four groups. The first group (Group 1) received only ARA-C, the second group (Group 2) received ARA-C and N-acetylcysteine (NAC), the third group (Group 3) received only NAC and the fourth group (Group 4) was the control group. The total oxidant status (TOS), the total antioxidant capacity and the oxidative stress index (OSI) measurements of the cornea and the conjunctiva were evaluated in these four groups. The mean TOS and OSI value was the highest in Group 1 and the lowest in Group 3. The differences in TOS and OSI values were statistically significant between Group 1 and Group 2. There are decreases in TOS and OSI values in rats which received ARA-C with NAC administration. NAC may have a protective effect on ARA-C-induced keratoconjunctivitis.
Literature
1.
go back to reference Al-Tweigeri T, Nabholtz JM, Mackey JR (1996) Ocular toxicity and cancer chemotherapy. Cancer 78:1359–1373CrossRefPubMed Al-Tweigeri T, Nabholtz JM, Mackey JR (1996) Ocular toxicity and cancer chemotherapy. Cancer 78:1359–1373CrossRefPubMed
2.
go back to reference Inaba H, Diouf B, Evans WE (2015) Cancer chemotherapy for pediatric patients. In: Orkin SH, Fisher DE, Ginsburg D, Look AT, Lux SE, Nathan DG (eds) Nathan ang Oski’s hematology and oncology of infancy and childhood, 8th edn., pp 1431–1432 Inaba H, Diouf B, Evans WE (2015) Cancer chemotherapy for pediatric patients. In: Orkin SH, Fisher DE, Ginsburg D, Look AT, Lux SE, Nathan DG (eds) Nathan ang Oski’s hematology and oncology of infancy and childhood, 8th edn., pp 1431–1432
3.
go back to reference Hollander DA, Aldave AJ (2004) Drug-induced corneal complications. Curr Opin Ophthalmol 15(6):541–548CrossRefPubMed Hollander DA, Aldave AJ (2004) Drug-induced corneal complications. Curr Opin Ophthalmol 15(6):541–548CrossRefPubMed
4.
go back to reference Hopen G, Mondino BJ, Johnson BL (1981) Corneal toxicity with systemic cytarabine. Am J Ophtalmol 91:500–504CrossRef Hopen G, Mondino BJ, Johnson BL (1981) Corneal toxicity with systemic cytarabine. Am J Ophtalmol 91:500–504CrossRef
5.
go back to reference Guthoff T, Tietze B, Meinhardt B, Becher J, Guthoff R (2010) Cytosine-arabinoside-induced keratopathy: a model of corneal proliferation kinetics. Ophthalmologica. 224(5):308–311CrossRefPubMed Guthoff T, Tietze B, Meinhardt B, Becher J, Guthoff R (2010) Cytosine-arabinoside-induced keratopathy: a model of corneal proliferation kinetics. Ophthalmologica. 224(5):308–311CrossRefPubMed
6.
go back to reference Patel AK, Sheehan W, Jenkins A, Lane C, Kell J (2011) Prophylactic treatment for cytosine arabinoside-induced keratoconjunctivitis. Int Ophthalmol 31(3):191–195CrossRefPubMed Patel AK, Sheehan W, Jenkins A, Lane C, Kell J (2011) Prophylactic treatment for cytosine arabinoside-induced keratoconjunctivitis. Int Ophthalmol 31(3):191–195CrossRefPubMed
7.
go back to reference Cadet J, Berger M, Douki T, Ravanat JL (1997) Oxidative damage to DNA: formation, measurement, and biological significance. Rev Physiol Biochem Pharmacol 131:1–87PubMed Cadet J, Berger M, Douki T, Ravanat JL (1997) Oxidative damage to DNA: formation, measurement, and biological significance. Rev Physiol Biochem Pharmacol 131:1–87PubMed
8.
go back to reference Lushchak VI (2014) Free radicals, reactive oxygen species, oxidative stress and its classification. Chem Biol Interact 28(224C):164–175CrossRef Lushchak VI (2014) Free radicals, reactive oxygen species, oxidative stress and its classification. Chem Biol Interact 28(224C):164–175CrossRef
9.
go back to reference Cuzzocrea S, Mazzon E, Costantino G, Serraino I, De Sarro A, Caputi AP (2000) Effects of n-acetylcysteine in a rat model of ischemia and reperfusion injury. Cardiovasc Res 47(3):537–548CrossRefPubMed Cuzzocrea S, Mazzon E, Costantino G, Serraino I, De Sarro A, Caputi AP (2000) Effects of n-acetylcysteine in a rat model of ischemia and reperfusion injury. Cardiovasc Res 47(3):537–548CrossRefPubMed
10.
go back to reference Koros C, Papalexi E, Anastasopoulos D, Kittas C, Kitraki E (2007) Effects of AraC treatment on motor coordination and cerebellar cytoarchitecture in the adult rat. a possible protective role of NAC. Neurotoxicology 28(1):83–92CrossRefPubMed Koros C, Papalexi E, Anastasopoulos D, Kittas C, Kitraki E (2007) Effects of AraC treatment on motor coordination and cerebellar cytoarchitecture in the adult rat. a possible protective role of NAC. Neurotoxicology 28(1):83–92CrossRefPubMed
11.
go back to reference Arica V, Demir IH, Tutanc M, Basarslan F, Arica S, Karcoıglu M, Öztürk H, Nacar A (2013) N-acetylcysteine prevents doxorubicin-induced cardiotoxicity in rats. Hum Exp Toxicol 32(6):655–661CrossRefPubMed Arica V, Demir IH, Tutanc M, Basarslan F, Arica S, Karcoıglu M, Öztürk H, Nacar A (2013) N-acetylcysteine prevents doxorubicin-induced cardiotoxicity in rats. Hum Exp Toxicol 32(6):655–661CrossRefPubMed
12.
go back to reference Erel O (2005) A new automated colorimetric method for measuring total oxidant status. Clin Biochem 38:1103–1111CrossRefPubMed Erel O (2005) A new automated colorimetric method for measuring total oxidant status. Clin Biochem 38:1103–1111CrossRefPubMed
13.
go back to reference Erel O (2004) A novel automated method to measure total antioxidant response against potent free radical reactions. Clin Biochem 37:112–119CrossRefPubMed Erel O (2004) A novel automated method to measure total antioxidant response against potent free radical reactions. Clin Biochem 37:112–119CrossRefPubMed
14.
go back to reference Lowry OH, Rosenbrough NJ, Far AL, Randel RJ (1951) Protein measurement with folin-phenol reagent. J Biol Chem 193:265–275PubMed Lowry OH, Rosenbrough NJ, Far AL, Randel RJ (1951) Protein measurement with folin-phenol reagent. J Biol Chem 193:265–275PubMed
15.
go back to reference Kosecik M, Erel O, Sevinc E, Selek S (2005) Increased oxidative stress in children exposed to passive smoking. Int J Cardiol 100:61–64CrossRefPubMed Kosecik M, Erel O, Sevinc E, Selek S (2005) Increased oxidative stress in children exposed to passive smoking. Int J Cardiol 100:61–64CrossRefPubMed
16.
go back to reference Geller HM, Cheng KY, Goldsmith NK, Romero AA, Zhang AL, Morris EJ et al (2001) Oxidative stress mediates neuronal DNA damage and apoptosis in response to cytosine arabinoside. J Neurochem 78(2):265–275CrossRefPubMed Geller HM, Cheng KY, Goldsmith NK, Romero AA, Zhang AL, Morris EJ et al (2001) Oxidative stress mediates neuronal DNA damage and apoptosis in response to cytosine arabinoside. J Neurochem 78(2):265–275CrossRefPubMed
17.
go back to reference McConkey DJ (1998) Biochemical determinants of apoptosis and necrosis. Toxicol Lett 99(3):157–168CrossRefPubMed McConkey DJ (1998) Biochemical determinants of apoptosis and necrosis. Toxicol Lett 99(3):157–168CrossRefPubMed
18.
go back to reference Shacter E, Williams JA, Hinson RM, Sentürker S, Lee YJ (2000) Oxidative stress interferes with cancer chemotherapy: inhibition of lymphoma cell apoptosis and phagocytosis. Blood 96(1):307–313PubMed Shacter E, Williams JA, Hinson RM, Sentürker S, Lee YJ (2000) Oxidative stress interferes with cancer chemotherapy: inhibition of lymphoma cell apoptosis and phagocytosis. Blood 96(1):307–313PubMed
19.
go back to reference Kucera GL, Capizzi RL (1992) 1-Beta-d-arabinofuranosylcytosine-diphosphate-choline is formed by the reversal of cholinephosphotransferase and not via cytidylyltransferase. Cancer Res 52(14):3886–3891PubMed Kucera GL, Capizzi RL (1992) 1-Beta-d-arabinofuranosylcytosine-diphosphate-choline is formed by the reversal of cholinephosphotransferase and not via cytidylyltransferase. Cancer Res 52(14):3886–3891PubMed
20.
go back to reference De Flora S, Izzotti A, D’Agostini F, Balansky RM (2001) Mechanisms of N-acetylcysteine in the prevention of DNA damage and cancer, with special reference to smoking-related end-points. Carcinogenesis 22(7):999–1013CrossRefPubMed De Flora S, Izzotti A, D’Agostini F, Balansky RM (2001) Mechanisms of N-acetylcysteine in the prevention of DNA damage and cancer, with special reference to smoking-related end-points. Carcinogenesis 22(7):999–1013CrossRefPubMed
21.
go back to reference Faintuch J, Aguilar PB, Nadalin W (1999) Relevance of N-acetylcysteine in clinical practice: fact, myth or consequence? Nutrition 15(2):177–179CrossRefPubMed Faintuch J, Aguilar PB, Nadalin W (1999) Relevance of N-acetylcysteine in clinical practice: fact, myth or consequence? Nutrition 15(2):177–179CrossRefPubMed
22.
go back to reference Ozdemir R, Yurttutan S, Sarı FN, Uysal B, Unverdi HG, Canpolat FE et al (2012) Antioxidant effects of N-acetylcysteine in a neonatal rat model of necrotizing enterocolitis. J Pediatr Surg 47(9):1652–1657CrossRefPubMed Ozdemir R, Yurttutan S, Sarı FN, Uysal B, Unverdi HG, Canpolat FE et al (2012) Antioxidant effects of N-acetylcysteine in a neonatal rat model of necrotizing enterocolitis. J Pediatr Surg 47(9):1652–1657CrossRefPubMed
23.
go back to reference Matteucci P, Carlo-Stella C, Di Nicola M, Magni M, Guidetti A, Marchesi M et al (2006) Topical prophylaxis of conjunctivitis induced by high-dose cytosine arabinoside. Haematologica 91:255–257PubMed Matteucci P, Carlo-Stella C, Di Nicola M, Magni M, Guidetti A, Marchesi M et al (2006) Topical prophylaxis of conjunctivitis induced by high-dose cytosine arabinoside. Haematologica 91:255–257PubMed
24.
go back to reference Mori T, Kato J, Yamane A, Aisa Y, Kawata Y, Ichimura M, Tsuneyama C, Yashima T, Ogawa Y, Tsubota K, Shigematsu N, Shimizu T, Okamoto S (2011) Prevention of cytarabine-induced kerato-conjunctivitis by eye rinse in patients receiving high-dose cytarabineand total body irradiation as a conditioning for hematopoietic stem cell transplantation. Int J Hematol. 94(3):261–265CrossRefPubMed Mori T, Kato J, Yamane A, Aisa Y, Kawata Y, Ichimura M, Tsuneyama C, Yashima T, Ogawa Y, Tsubota K, Shigematsu N, Shimizu T, Okamoto S (2011) Prevention of cytarabine-induced kerato-conjunctivitis by eye rinse in patients receiving high-dose cytarabineand total body irradiation as a conditioning for hematopoietic stem cell transplantation. Int J Hematol. 94(3):261–265CrossRefPubMed
25.
go back to reference Samarawickrama C, Ioannidis AS, Wechsler AW, Watson SL (2014) Bilateral corneal infections associated with topical steroid therapy prophylaxis for cytarabine arabinoside-induced keratoconjunctivitis. Leukemia 28(1):220–222CrossRefPubMed Samarawickrama C, Ioannidis AS, Wechsler AW, Watson SL (2014) Bilateral corneal infections associated with topical steroid therapy prophylaxis for cytarabine arabinoside-induced keratoconjunctivitis. Leukemia 28(1):220–222CrossRefPubMed
26.
go back to reference Watson SL, Coroneo MT (2001) Steroids and the eye. Med Today 2:79–85 Watson SL, Coroneo MT (2001) Steroids and the eye. Med Today 2:79–85
27.
go back to reference Tomlinson D (2010) Eyes-oculer complications. In: Tomlinson D, Kline NE (eds) Pediatric oncology nursing, 2nd edn. Springer, Heidelberg, pp 383–385CrossRef Tomlinson D (2010) Eyes-oculer complications. In: Tomlinson D, Kline NE (eds) Pediatric oncology nursing, 2nd edn. Springer, Heidelberg, pp 383–385CrossRef
Metadata
Title
N-acetylcysteine supplementation reduces oxidative stress for cytosine arabinoside in rat model
Authors
Yasemin Isik Balci
Semra Acer
Ramazan Yagci
Vural Kucukatay
Hakan Sarbay
Kerem Bozkurt
Aziz Polat
Publication date
01-02-2017
Publisher
Springer Netherlands
Published in
International Ophthalmology / Issue 1/2017
Print ISSN: 0165-5701
Electronic ISSN: 1573-2630
DOI
https://doi.org/10.1007/s10792-016-0259-7

Other articles of this Issue 1/2017

International Ophthalmology 1/2017 Go to the issue